{"content":"<li class=\"n-box-item date-title\" data-end=\"1460779199\" data-start=\"1460692800\" data-txt=\"Sunday, December 22, 2019\">Friday, April 15, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3173487\" data-ts=\"1460762913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MIME\" target=\"_blank\">MIME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173487-mimecast-falls-3_3-after-goldman-drops-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mimecast falls 3.3% after Goldman drops to Neutral</a></h4><ul>   <li>E-mail and data safety firm Mimecast (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MIME\" title=\"Mimecast\">MIME</a>) <font color=\"red\">fell 3.3%</font> today and hit its lowest point since January after Goldman Sachs downgraded the company to Neutral from Buy.</li>    <li>The firm also reduced its price target to $10.50, now promising just 27.5% upside from today's close of $8.23.</li>    <li>There's significant market opportunity, analyst Heather Bellini says, but <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/04/7844729/goldman-removes-mimecast-from-buy-list-downgrades-to-neu\" target=\"_blank\">competition has stiffened</a>, including Microsoft's addition of built-in security on Office 365.</li>    <li>\u201cOur Buy was based on MIME\u2019s ability to drive revenue upside by upselling its existing customers as well as expanding its customer base as it capitalized on the migration of email infrastructure workloads to the cloud,\" she writes.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3959076-mimecast-climbs-back-post-ipo-swoon\" target=\"_blank\"><b>Mimecast Climbs Back From Post-IPO Swoon »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173487\" data-linked=\"Mimecast falls 3.3% after Goldman drops to Neutral\" data-tweet=\"$MIME - Mimecast falls 3.3% after Goldman drops to Neutral https://seekingalpha.com/news/3173487-mimecast-falls-3_3-after-goldman-drops-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3173487-mimecast-falls-3_3-after-goldman-drops-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173486\" data-ts=\"1460761091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLMT\" target=\"_blank\">CLMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173486-calumet-specialty-productsminus-31-ah-after-ending-cash-distribution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Calumet Specialty Products -31% AH after ending cash distribution</a></h4><ul>\n<li>Calumet Specialty Products Partners (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a>) <font color=\"red\">-31.8%</font> AH after suspending its quarterly cash distribution.</li>\n<li>CLMT says the distribution halt and a $400M debt placement will  \"position us to manage our capital structure with prudence and  conservatism during a challenging period for our business.\"</li>\n<li>CLMT also says it expects to report a Q1 net loss of $59M-$83M; <a href=\"http://www.marketwatch.com/story/calumet-plummets-nearly-30-after-ending-cash-distribution-2016-04-15\" target=\"_blank\">analyst consensus</a> estimated a $19M net loss.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3172472-credit-suisse-downgrades-refiners-valero-alon-partners-northern-tier-calumet\" target=\"_blank\"><strong>Credit Suisse downgrades refiners Valero, Alon Partners, Northern Tier, Calumet</strong></a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173486\" data-linked=\"Calumet Specialty Products -31% AH after ending cash distribution\" data-tweet=\"$CLMT - Calumet Specialty Products -31% AH after ending cash distribution https://seekingalpha.com/news/3173486-calumet-specialty-productsminus-31-ah-after-ending-cash-distribution?source=tweet\" data-url=\"https://seekingalpha.com/news/3173486-calumet-specialty-productsminus-31-ah-after-ending-cash-distribution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>73&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173479\" data-ts=\"1460757025\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNEQ\" target=\"_blank\">SUNEQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173479-reuters-sunedison-to-file-for-bankruptcy-soon-sunday\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: SunEdison to file for bankruptcy as soon as Sunday</a></h4><ul>   <li>SunEdison (SUNE) -- <font color=\"red\">down 39.4%</font> today -- has <font color=\"red\">fallen another 20.7%</font> after hours as Reuters says a source told it the company will <a href=\"http://www.reuters.com/article/us-sunedison-inc-debt-idUSKCN0XC1GX\" target=\"_blank\">file for bankruptcy</a> as soon as Sunday evening.</li>    <li>That would be less of a surprise than it might have been otherwise, as the company <a href=\"https://seekingalpha.com/news/3173391-sunedison-sinks-26-percent-acknowledges-bankruptcy-loan-talks\" target=\"_blank\">acknowledged today</a> it had entered confidential talks in March regarding debtor-in-possession financing.</li>    <li>The source said the timing of the filing isn't final.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3965578-sunedison-will-still-go-bankrupt-despite-8-k-whitewash-misses-2_5-million-coupon-payment-debt\" target=\"_blank\"><b>SunEdison Will Still Go Bankrupt Despite The 8-K Whitewash - Misses $2.5 Million Coupon Payment On Debt »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173479\" data-linked=\"Reuters: SunEdison to file for bankruptcy as soon as Sunday\" data-tweet=\"$SUNEQ - Reuters: SunEdison to file for bankruptcy as soon as Sunday https://seekingalpha.com/news/3173479-reuters-sunedison-to-file-for-bankruptcy-soon-sunday?source=tweet\" data-url=\"https://seekingalpha.com/news/3173479-reuters-sunedison-to-file-for-bankruptcy-soon-sunday\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1072&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173475\" data-ts=\"1460756218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173475-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/VIV\" title=\"Telefonica Brasil, S.A\">VIV</a> <font color=\"green\">+11.8%</font>. <a href=\"https://seekingalpha.com/symbol/GOV-OLD\" title=\"Government Properties Income Trust\">GOV-OLD</a> <font color=\"green\">+2.7%</font>. <a href=\"https://seekingalpha.com/symbol/CARA\" title=\"Cara Therapeutics Inc.\">CARA</a> <font color=\"green\">+1.9%</font>. <a href=\"https://seekingalpha.com/symbol/XNPT\" title=\"XenoPort, Inc.\">XNPT</a> <font color=\"green\">+1.6%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.: </b><a href=\"https://seekingalpha.com/symbol/MGA\" title=\"Magna International Inc.\">MGA</a> <font color=\"red\">-11.1%</font>. <a href=\"https://seekingalpha.com/symbol/WTI\" title=\"W&amp;T Offshore, Inc.\">WTI</a> <font color=\"red\">-3.2%</font>. <a href=\"https://seekingalpha.com/symbol/FOXF\" title=\"Fox Factory Holding Corp\">FOXF</a> <font color=\"red\">-1.8%</font>. <a href=\"https://seekingalpha.com/symbol/HMY\" title=\"Harmony Gold Mining Company Limited\">HMY</a> <font color=\"red\">-1.8%</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173475\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$VIV $GOV-OLD $CARA - After Hours Gainers / Losers https://seekingalpha.com/news/3173475-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3173475-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173474\" data-ts=\"1460755967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TST\" target=\"_blank\">TST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173474-thestreet-nominates-chairman-kramer-hall-vs-spear-point-nominees\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TheStreet nominates Chairman Kramer, Hall vs. Spear Point nominees</a></h4><ul>   <li>TheStreet (<a href=\"https://seekingalpha.com/symbol/TST\" title=\"TheStreet, Inc.\">TST</a> <font color=\"red\">-4.9%</font>) -- continuing to search for a CEO after <a href=\"https://seekingalpha.com/news/3129376-thestreet-ceo-demarse-leaving-company\" target=\"_blank\">Elisabeth DeMarse's departure</a> -- says in a filing that it's nominated Larry Kramer (chairman and interim CEO) to stand for election in a <a href=\"https://www.sec.gov/Archives/edgar/data/1080056/000161577416004998/s103029_8k.htm\" target=\"_blank\">three-year term as a Class II director</a>, in order to rebalance director classes.</li>    <li>Kramer would resign his Class I position to take the new designation.</li>    <li>The company also nominated Keith Hall for a three-year slot as Class II director -- with Hall and Kramer serving as the company's preferences vs. those of Spear Point Capital Management, which proposed two nominees.</li>\n<li>That notice didn't comply with bylaws, but TheStreet says it still interviewed the candidates and determined that Kramer and Hall were still its best choices.</li>    <li>TheStreet also updated its corporate governance guidelines, saying it intends to keep separate the positions of chairman and CEO, and eliminate the lead independent director position.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3859846-thestreet-looks-cheap-also-looks-options\" target=\"_blank\"><b>TheStreet Looks Cheap, But It Also Looks Out Of Options »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173474\" data-linked=\"TheStreet nominates Chairman Kramer, Hall vs. Spear Point nominees\" data-tweet=\"$TST - TheStreet nominates Chairman Kramer, Hall vs. Spear Point nominees https://seekingalpha.com/news/3173474-thestreet-nominates-chairman-kramer-hall-vs-spear-point-nominees?source=tweet\" data-url=\"https://seekingalpha.com/news/3173474-thestreet-nominates-chairman-kramer-hall-vs-spear-point-nominees\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173463\" data-ts=\"1460751969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173463-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li> <b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KOL' title='Market Vectors Coal ETF'>KOL</a> <font color='green'>+10.34%</font>. <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a> <font color='green'>+9.45%</font>. <a href='https://seekingalpha.com/symbol/REMX' title='Market Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color='green'>+7.52%</font>. <a href='https://seekingalpha.com/symbol/GDXJ' title='Market Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='green'>+7.08%</font>. <a href='https://seekingalpha.com/symbol/EWA' title='iShares MSCI Australia ETF'>EWA</a>&nbsp;<font color='green'>+6.89%</font>. </li><li> &nbsp;<b>Losers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-8.18%</font>. <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='red'>-3.7%</font>. <a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a> <font color='red'>-1.05%</font>. <a href='https://seekingalpha.com/symbol/XLP' title='Consumer Staples Select Sector SPDR ETF'>XLP</a> <font color='red'>-0.69%</font>. <a href='https://seekingalpha.com/symbol/SGOL' title='ETFS Physical Swiss Gold Trust ETF'>SGOL</a> <font color='red'>-0.50%</font>.<br />&nbsp; </li> </ul><div class=\"tiny-share-widget\" data-id=\"3173463\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$KOL $URA $REMX - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3173463-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3173463-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173452\" data-ts=\"1460749543\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173452-new-street-on-sprint-something-big-needs-to-change\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New Street on Sprint: &#39;Something big needs to change&#39;</a></h4><ul>   <li>\"Investors should ignore all of the issues around EIP and handset lease plans and the vehicles that have been set up to finance these,\" says New Street Research as it looks ahead to Sprint (<a href=\"https://seekingalpha.com/symbol/S\" title=\"Sprint Corporation\">S</a> <font color=\"green\">+3.3%</font>) earnings coming April 26.</li>    <li>Instead, stakeholders should see a <a href=\"http://www.fiercewireless.com/story/something-big-needs-change-sprint-new-street-analysts-say/2016-04-15\" target=\"_blank\">closing window</a> for the struggling carrier and focus on ARPU, churn, and share of gross adds it attained. Sprint shares got a pickup yesterday as a <a href=\"https://seekingalpha.com/news/3173169-sprint-2_6-percent-alongside-claures-possible-hint-q1-phone-gains\" target=\"_blank\">tweet from CEO Marcelo Claure</a> spurred chatter that T-Mobile might not be the only one with postpaid phone growth.</li>    <li>New Street says Sprint will need 25% of industry gross adds for three years to offset its repricing. And promotion-driven ARPU gains that it expects of $0.69 (to $59 for the quarter) would still bean a 7.5% Y/Y decline in ARPU.</li>    <li>One silver lining: The firm says it's \"leery\" of shorting the stock, considering the value of spectrum holdings.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3949406-sprints-spectrum-worth-premium-discount\" target=\"_blank\"><b>Sprint's Spectrum Is Worth A Premium, Not A Discount »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173452\" data-linked=\"New Street on Sprint: &#39;Something big needs to change&#39;\" data-tweet=\"$S - New Street on Sprint: &#39;Something big needs to change&#39; https://seekingalpha.com/news/3173452-new-street-on-sprint-something-big-needs-to-change?source=tweet\" data-url=\"https://seekingalpha.com/news/3173452-new-street-on-sprint-something-big-needs-to-change\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173451\" data-ts=\"1460749497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173451-another-sale-rumor-stokes-synergy-pharmaceuticals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another sale rumor stokes Synergy Pharmaceuticals</a></h4><ul>\n<li>Allergan (NYSE:<a href=\"https://seekingalpha.com/symbol/AGN\" title=\"Allergan plc\">AGN</a>) is the <a href=\"http://www.streetinsider.com/Hot+M+and+A/Allergan+%28AGN%29+Takeover+of+Synergy+Pharmaceuticals+%28SGYP%29+May+be+Imminent+-+Source/11509320.html\" target=\"_blank\">purported suitor</a>.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/SGYP\" title=\"Synergy Pharmaceuticals, Inc.\">SGYP</a> <font color=\"green\">+6.5%</font>\n</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3963437-termination-allergan-pfizer-deal-bad\" target=\"_blank\">Why The Termination Of The Allergan-Pfizer Deal Isn't Too Bad After All</a> (April 6)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173451\" data-linked=\"Another sale rumor stokes Synergy Pharmaceuticals\" data-tweet=\"$AGN $AGN $SGYP-OLD - Another sale rumor stokes Synergy Pharmaceuticals https://seekingalpha.com/news/3173451-another-sale-rumor-stokes-synergy-pharmaceuticals?source=tweet\" data-url=\"https://seekingalpha.com/news/3173451-another-sale-rumor-stokes-synergy-pharmaceuticals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173450\" data-ts=\"1460749379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JOY\" target=\"_blank\">JOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173450-coal-bankruptcies-are-good-news-for-joy-global-baird-analysts-say\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coal bankruptcies are good news for Joy Global, Baird analysts say</a></h4><ul>     <li>Recent coal bankruptcies from Peabody Energy and others actually are <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/04/15/joy-global-why-coal-bankruptcies-are-good-news/\" target=\"_blank\">good news</a> for Joy Global (<a href=\"https://seekingalpha.com/symbol/JOY\" title=\"Joy Global Inc.\">JOY</a> <font color=\"green\">+4.4%</font>) - indeed a counter-intuitive positive catalyst - Baird's Mircea Dobre and Joseph Grabowski claim.</li>     <li>The analysts say they take their cue from JOY CEO Ted Doheny, who told them that he views pre-filing behavior as \u201cstressing equipment and suppliers\u201d forcing suppliers to move to cash up front mode in some cases, while post-filing behavior is akin to \u201cstabilization,\u201d particularly when it comes to demand for service and parts, items directly related to current and future customer cash flow generation.</li>\n<li>\"The near term remains rocky but be brave... buy,\" the Baird pair says.</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3963698-joy-heading-fresh-selloff\" target=\"_blank\">Is Joy heading for a fresh selloff?</a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173450\" data-linked=\"Coal bankruptcies are good news for Joy Global, Baird analysts say\" data-tweet=\"$JOY - Coal bankruptcies are good news for Joy Global, Baird analysts say https://seekingalpha.com/news/3173450-coal-bankruptcies-are-good-news-for-joy-global-baird-analysts-say?source=tweet\" data-url=\"https://seekingalpha.com/news/3173450-coal-bankruptcies-are-good-news-for-joy-global-baird-analysts-say\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173447\" data-ts=\"1460747926\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NE\" target=\"_blank\">NE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173447-noble-corp-wins-shell-rig-extension-loses-leverage-barclays-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Corp. wins Shell rig extension but loses leverage, Barclays says</a></h4><ul>     <li>Noble Corp. (<a href=\"https://seekingalpha.com/symbol/NE\" title=\"Noble Corporation plc\">NE</a> <font color=\"green\">+2.5%</font>) has <a href=\"http://phx.corporate-ir.net/phoenix.zhtml?c=98046&amp;p=irol-reportsOther\" target=\"_blank\">won a two-year extension</a> on an agreement with Royal Dutch Shell (<a href=\"https://seekingalpha.com/symbol/RDS.A\" title=\"Royal Dutch Shell plc\">RDS.A</a>, <a href=\"https://seekingalpha.com/symbol/RDS.B\" title=\"Royal Dutch Shell plc\">RDS.B</a>) for a rig working in the North Sea, but Barclays thinks NE is <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/04/15/offshore-drillers-losing-leverage/?mod=BOL_hp_blog_stw\" target=\"_blank\">losing contract negotiating leverage</a> since the extension allows Shell to cancel the contract for convenience.</li>     <li>The firm sees the net valuation impact of the changes - with the two-year Shell extension at a 62% lower dayrate of $88K - as minimal but an overall negative for the company and the industry, since more customers may begin demanding termination for convenience rights in an increasingly competitive offshore rig environment.</li>     <li>Barclays maintains NE at Underweight with a $6 price target.</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3964830-noble-corp-potential-long-term-dividend-play\" target=\"_blank\"><strong>Noble Corp. has potential as a long-term dividend play</strong></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173447\" data-linked=\"Noble Corp. wins Shell rig extension but loses leverage, Barclays says\" data-tweet=\"$NE $NE $RDS.A - Noble Corp. wins Shell rig extension but loses leverage, Barclays says https://seekingalpha.com/news/3173447-noble-corp-wins-shell-rig-extension-loses-leverage-barclays-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3173447-noble-corp-wins-shell-rig-extension-loses-leverage-barclays-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173442\" data-ts=\"1460744747\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FNMA\" target=\"_blank\">FNMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173442-gses-tumble-oral-arguments-heard\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GSEs tumble as oral arguments heard</a></h4><ul>\n<li>Investors today are presenting arguments to a federal appeals panel that the August 2012 net worth sweeps of Fannie Mae (<a href=\"https://seekingalpha.com/symbol/FNMA\" title=\"Fannie Mae\">OTCQB:FNMA</a> <font color=\"red\">-12%</font>) and Freddie Mac (<a href=\"https://seekingalpha.com/symbol/FMCC\" title=\"Freddie Mac\">OTCQB:FMCC</a> <font color=\"red\">-13.8%</font>) were illegal. There's no word publicly yet on how things went down, but the direction of the stocks may give a clue.</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3965358-fannie-mae-freddie-mac-generational-investment-opportunty\" target=\"_blank\">Fannie Mae And Freddie Mac: A Generational Investment Opportunty</a> (April 14)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173442\" data-linked=\"GSEs tumble as oral arguments heard\" data-tweet=\"$FNMA $FNMA $FMCC - GSEs tumble as oral arguments heard https://seekingalpha.com/news/3173442-gses-tumble-oral-arguments-heard?source=tweet\" data-url=\"https://seekingalpha.com/news/3173442-gses-tumble-oral-arguments-heard\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>99&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173429\" data-ts=\"1460739564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BDRAF\" target=\"_blank\">BDRAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173429-bloomberg-bombardier-rejects-canadian-aid-proposal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Bombardier rejects Canadian aid proposal</a></h4><ul>\n<li>Bombardier (<a href=\"https://seekingalpha.com/symbol/BDRAF\" title=\"Bombardier Inc.A\">OTCQX:BDRAF</a>, <a href=\"https://seekingalpha.com/symbol/BDRBF\" title=\"Bombardier Inc.B\">OTCQX:BDRBF</a>) <a href=\"http://www.bloomberg.com/news/articles/2016-04-15/bombardier-said-to-reject-aid-proposal-from-canadian-government\" target=\"_blank\">rejects an initial investment proposal</a> from the  Canadian government to shore up the company\u2019s finances, as  the two sides remain at odds over corporate governance and other issues, Bloomberg reports.</li>\n<li>The federal government seeks a more favorable deal than the one struck  by the province of Quebec to support the CSeries jet program, and a deal  before Bombardier\u2019s annual meeting on April 29 now is unlikely, according to the report.</li>\n<li>The disagreement is a potential setback for Bombardier just as the company is beginning to get traction for its CSeries program; shares <font color=\"green\">+9.7%</font>.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3173251-dow-jones-bombardier-near-deal-sell-125-cseries-jets-delta\" target=\"_blank\"><strong>Dow Jones: Bombardier near deal to sell up to 125 CSeries jets to Delta</strong></a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173429\" data-linked=\"Bloomberg: Bombardier rejects Canadian aid proposal\" data-tweet=\"$BDRAF $BDRAF $BDRBF - Bloomberg: Bombardier rejects Canadian aid proposal https://seekingalpha.com/news/3173429-bloomberg-bombardier-rejects-canadian-aid-proposal?source=tweet\" data-url=\"https://seekingalpha.com/news/3173429-bloomberg-bombardier-rejects-canadian-aid-proposal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173422\" data-ts=\"1460739128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTCT\" target=\"_blank\">PTCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173422-advisor-to-uk-health-service-backs-ptcs-translarna-shares-up-44\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Advisor to UK Health Service backs PTC&#39;s Translarna; shares up 44%</a></h4><ul>\n<li>Micro cap PTC Therapeutics (<a href=\"https://seekingalpha.com/symbol/PTCT\" title=\"PTC Therapeutics\">PTCT</a> <font color=\"green\">+43.5%</font>) jumps on a 5x surge in volume in response to its announcement that the UK's National Institute for Health and Care Excellence (NICE), an advisor to Britain's National Health Service on costs and services, has recommended Translarna (ataluren) for ambulatory patients at least five years old with nonsense mutation Duchenne muscular dystrophy (nmDMD) under a Managed Access Agreement (MAA) with NHS England. Patient access is subject to the finalization of NICE's draft guidance, expected next month.</li>\n<li>The company and NHS England are finalizing an MAA that outlines the financial and clinical details pertaining to the use of Translarna, including a confidential financial arrangement. NICE will review its guidance in five years after the company collects further data on Translarna's efficacy in nmDMD.</li>\n<li>The European Commission approved Translarna, a protein restoration therapy designed to enable the formation of a functioning protein in patients with genetic disorders caused by <a href=\"http://en.wikipedia.org/wiki/Nonsense_mutation\" target=\"_blank\">nonsense mutation</a>, in August 2014. Two months ago, though, the FDA rejected the company's marketing application stating it was not complete enough for review.</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/3956755-ptc-therapeutics-discounted-enterprise-value-despite-current-sales\" target=\"_blank\">PTC Therapeutics: Discounted To No Enterprise Value Despite Current Sales</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173422\" data-linked=\"Advisor to UK Health Service backs PTC&#39;s Translarna; shares up 44%\" data-tweet=\"$PTCT - Advisor to UK Health Service backs PTC&#39;s Translarna; shares up 44% https://seekingalpha.com/news/3173422-advisor-to-uk-health-service-backs-ptcs-translarna-shares-up-44?source=tweet\" data-url=\"https://seekingalpha.com/news/3173422-advisor-to-uk-health-service-backs-ptcs-translarna-shares-up-44\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173423\" data-ts=\"1460738461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173423-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers/ Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/GBSN-OLD\" title=\"Great Basin Scientific, Inc.\">GBSN</a> <font color=\"green\">+85%</font>. <a href=\"https://seekingalpha.com/symbol/PTCT\" title=\"PTC Therapeutics\">PTCT</a> <font color=\"green\">+42%</font>. <a href=\"https://seekingalpha.com/symbol/ATV\" title=\"Acorn International, Inc.\">ATV</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/WG\" title=\"Willbros Group, Inc.\">WG</a> <font color=\"green\">+22%</font>. <a href=\"https://seekingalpha.com/symbol/NAVB\" title=\"Navidea Biopharmaceuticals\">NAVB</a> <font color=\"green\">+21%</font>. <a href=\"https://seekingalpha.com/symbol/ORPN\" title=\"Bio Blast Pharma\">ORPN</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/EVAR\" title=\"Lombard Medical, Inc.\">EVAR</a> <font color=\"green\">+17%</font>. <a href=\"https://seekingalpha.com/symbol/REXX\" title=\"Rex Energy Corporation\">REXX</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/JTPY\" title=\"JetPay Corporation\">JTPY</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/EBIX\" title=\"Ebix Inc\">EBIX</a> <font color=\"green\">+11%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/CLRB\" title=\"Cellectar Biosciences, Inc.\">CLRB</a> <font color=\"red\">-31%</font>. FREE <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/BSPM\" title=\"Biostar Pharmaceutic\">OTC:BSPM</a> <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/SMCI\" title=\"Super Micro Computer, Inc.\">SMCI</a> <font color=\"red\">-18%</font>. <a href=\"https://seekingalpha.com/symbol/XXIA\" title=\"Ixia\">XXIA</a> <font color=\"red\">-17%</font>. <a href=\"https://seekingalpha.com/symbol/RPRX\" title=\"Repros Therapeutics Inc.\">RPRX</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/RLYP\" title=\"Relypsa, Inc.\">RLYP</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CDNA\" title=\"CareDx\">CDNA</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/CDRB\" title=\"Code Rebel Corp\">CDRB</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/RGLS\" title=\"Regulus Therapeutics\">RGLS</a> <font color=\"red\">-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173423\" data-linked=\"Midday Gainers/ Losers\" data-tweet=\"$GBSN-OLD $PTCT $ATV - Midday Gainers/ Losers https://seekingalpha.com/news/3173423-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3173423-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173425\" data-ts=\"1460738372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HP\" target=\"_blank\">HP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173425-superior-energy-helmerich-payne-patterson-downgraded-j-p-morgan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Superior Energy, Helmerich &amp; Payne, Patterson downgraded at J.P. Morgan</a></h4><ul>     <li>Investor hopes of further gains in oil prices are unrealistic, and expectations for U.S. onshore drilling stocks are sporting inflated multiples, J.P. Morgan analysts say as they <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/04/7845338/jpmorgan-downgrades-superior-energy-to-neutral-helmerich\" target=\"_blank\">reduce ratings</a> where expectations may have jumped too far too fast.</li>     <li>The firm downgrades Helmerich &amp; Payne (<a href=\"https://seekingalpha.com/symbol/HP\" title=\"Helmerich &amp; Payne Inc.\">HP</a> <font color=\"red\">-2.6%</font>) and Patterson-UTI (<a href=\"https://seekingalpha.com/symbol/PTEN\" title=\"Patterson-UTI Energy, Inc.\">PTEN</a> <font color=\"red\">-3.6%</font>) to Underweight from Neutral with respective $39 and $13 price targets, saying that while both have strong management teams and solid execution should continue, it is \"skeptical of the macro environment required to deliver on the current elevated multiples embedded in each stock.\"</li>     <li>Superior Energy (<a href=\"https://seekingalpha.com/symbol/SPN\" title=\"Superior Energy Services, Inc.\">SPN</a> <font color=\"red\">-1.2%</font>) is downgraded to Neutral from Overweight with a $13 price target, with JPM saying SPN has faced several challenges in recent quarters and likely will have a difficult H1, although cost adjustments should provide some support to the company in H2.</li>\n<li>Now read <a href=\"https://seekingalpha.com/news/3173421-anadarko-antero-upgraded-southwestern-ep-energy-cut-j-p-morgan\" target=\"_blank\"><strong>Anadarko, Antero upgraded; Southwestern, EP Energy cut at J.P. Morgan</strong></a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173425\" data-linked=\"Superior Energy, Helmerich &amp; Payne, Patterson downgraded at J.P. Morgan\" data-tweet=\"$HP $HP $PTEN - Superior Energy, Helmerich &amp; Payne, Patterson downgraded at J.P. Morgan https://seekingalpha.com/news/3173425-superior-energy-helmerich-payne-patterson-downgraded-j-p-morgan?source=tweet\" data-url=\"https://seekingalpha.com/news/3173425-superior-energy-helmerich-payne-patterson-downgraded-j-p-morgan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173407\" data-ts=\"1460732968\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173407-sell-side-gives-thumbs-up-to-citi-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-side gives thumbs up to Citi results</a></h4><ul>\n<li>\"Citi (NYSE:<a href=\"https://seekingalpha.com/symbol/C\" title=\"Citigroup Inc.\">C</a>) is plenty cheap and management continues to make the company simpler, smaller, safer and stronger,\" says Evercore's Glenn Schorr. [It's] \"a message that is likely to resonate with regulators and bring better capital returns over time.\"</li>\n<li><a href=\"http://blogs.wsj.com/moneybeat/2016/04/15/citigroup-earnings-live-analysis/\" target=\"_blank\"><em>WSJ</em> blog</a></li>\n<li>UBS: \"These better than expected results, combined with Citi specific regulatory headwinds which seem to be fading (i.e. the positive living will outcome) should allow for sentiment around Citi shares to improve.\"</li>\n<li>Wells Fargo says positives included inline capital market performance, visible operating leverage improvement, and continued expansion of capital ratios. Energy was negative but expected.</li>\n<li>The banks are in the red today, but Citi is managing a <font color=\"green\">0.9% gain</font>. The conference call is just getting underway. <a href=\"http://www.citigroup.com/citi/investor/data/p160415a.pdf?ieNocache=83\" target=\"_blank\">Presentation slides here</a>.</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3965520-b-citigroup-b-bad-first-quarter-results-beat-estimates\" target=\"_blank\"><b>Citigroup</b>: Bad First Quarter Results But It Beat The Estimates</a> (April 15)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173407\" data-linked=\"Sell-side gives thumbs up to Citi results\" data-tweet=\"$C - Sell-side gives thumbs up to Citi results https://seekingalpha.com/news/3173407-sell-side-gives-thumbs-up-to-citi-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3173407-sell-side-gives-thumbs-up-to-citi-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173395\" data-ts=\"1460730619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BATS\" target=\"_blank\">BATS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173395-bats-global-higher-in-opening-trades\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bats Global higher in opening trades</a></h4><ul>\n<li>After pricing its IPO at the high end of the expected range of $17-$19, Bats Global (BATS:<a href=\"https://seekingalpha.com/symbol/BATS\" title=\"BATS Global Markets\">BATS</a>) is changing hands at $22.88 in opening action.</li>\n<li>The stock is trading on Bats' own exchange and to this point has avoided the embarrassing technical issues which scuttled the company's first attempt at going public nearly four years ago.</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3965200-b-bats-b-b-global-b-markets-put-watch-list\" target=\"_blank\"><b>BATS</b> <b>Global</b> Markets: Put It On Watch List</a> (April 14)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173395\" data-linked=\"Bats Global higher in opening trades\" data-tweet=\"$BATS - Bats Global higher in opening trades https://seekingalpha.com/news/3173395-bats-global-higher-in-opening-trades?source=tweet\" data-url=\"https://seekingalpha.com/news/3173395-bats-global-higher-in-opening-trades\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173391\" data-ts=\"1460730049\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUNEQ\" target=\"_blank\">SUNEQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173391-sunedison-sinks-26-acknowledges-bankruptcy-loan-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunEdison sinks 26%; acknowledges bankruptcy loan talks</a></h4><ul>   <li>SunEdison (SUNE), which <font color=\"green\">jumped 59%</font> yesterday among its recent volatile trades, is <font color=\"red\">25.9% lower</font> today as it acknowledges entering bankruptcy loan negotiations.</li>    <li>In this <a href=\"https://www.sec.gov/Archives/edgar/data/945436/000119312516542384/d181263d8k.htm\" target=\"_blank\">morning's 8-K</a>, the company said it and certain of its first and second lien lenders entered into confidentiality agreements on March 17 to discuss debtor-in-possession financing.</li>    <li>SunEdison projected $779M in cash use for Q1, and told creditors it would need a $310M loan to fund it through any bankruptcy process.</li>    <li>The company is in talks to <a href=\"http://www.reuters.com/article/us-sunedison-inc-india-idUSKCN0XB18X?feedType=nl&amp;feedName=innovationNews&amp;utm_source=Sailthru&amp;utm_medium=email&amp;utm_campaign=US%20Deals%20Today%202016-04-15&amp;utm_term=US%20Deals%20Today\" target=\"_blank\">sell minority positions</a> in its Indian solar projects to Fortum, a utility controlled by the country of Finland.</li>    <li>Fortum said it was planning to put \u20ac200M-\u20ac400M into solar projects in India, and is interested in SunEdison's projects, including a proposed 500-MW plant in Andhra Pradesh. SunEdison has about 600 MW of projects constructed and financed in the country, with plans for another 1,700 MW in the coming year.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3965431-brighter-days-ahead-sunedison\" target=\"_blank\"><b>Brighter Days Ahead For SunEdison »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173391\" data-linked=\"SunEdison sinks 26%; acknowledges bankruptcy loan talks\" data-tweet=\"$SUNEQ - SunEdison sinks 26%; acknowledges bankruptcy loan talks https://seekingalpha.com/news/3173391-sunedison-sinks-26-acknowledges-bankruptcy-loan-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3173391-sunedison-sinks-26-acknowledges-bankruptcy-loan-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>194&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173389\" data-ts=\"1460729762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173389-another-indignity-wells-fargo-downgraded\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another indignity as Wells Fargo downgraded</a></h4><ul>\n<li>All of a sudden, it's the \"Too Big To Fail\" class favorite that's under the gun.</li>\n<li>First, there have been a number of articles suggesting Wells Fargo (NYSE:<a href=\"https://seekingalpha.com/symbol/WFC\" title=\"Wells Fargo &amp; Co.\">WFC</a>) as the big lender <a href=\"https://seekingalpha.com/news/3172869-wells-fargos-risky-energy-bets-turn-bad\" target=\"_blank\">playing loosest and fastest</a> in the now-crashed energy patch. Then it was D.C. regulators who lumped Wells Fargo in with the usual suspects <a href=\"https://seekingalpha.com/news/3172855-d-c-rejects-living-wills-major-banks\" target=\"_blank\">as they rejected</a> nearly all of the country's biggest lenders' living wills. Third, bank earnings season is underway, and while JPMorgan, Bank of America, and Citigroup partied after their somewhat lame but better-than-hoped results, Wells Fargo <a href=\"https://seekingalpha.com/news/3173086-wells-fargo-lower-income-slips-energy-provisions-rise\" target=\"_blank\">has sold off a bit </a>following its report.</li>\n<li>Piper Jaffray has seen enough and today <a href=\"http://www.streetinsider.com/Analyst+Comments/Piper+Jaffray+Downgrades+Wells+Fargo+%28WFC%29+to+Underweight/11507304.html\" target=\"_blank\">downgrades to</a> Underweight from Neutral. It's the bank's 2nd downgrade this week. Wells is <font color=\"red\">lower by 1.25%</font> today and <font color=\"red\">12.1%</font> Y/Y - better than Citi's <font color=\"red\">14% decline</font>, but worse than Bank of America's <font color=\"red\">10% loss</font> and JPMorgan's <font color=\"red\">3% fall</font>.</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3965502-b-wells-b-b-fargo-b-problems-finally\" target=\"_blank\"><b>Wells</b> <b>Fargo</b>: Some Problems, Finally?</a> (April 15)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173389\" data-linked=\"Another indignity as Wells Fargo downgraded\" data-tweet=\"$WFC - Another indignity as Wells Fargo downgraded https://seekingalpha.com/news/3173389-another-indignity-wells-fargo-downgraded?source=tweet\" data-url=\"https://seekingalpha.com/news/3173389-another-indignity-wells-fargo-downgraded\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173388\" data-ts=\"1460729706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAW\" target=\"_blank\">CAW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173388-cca-industries-reports-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CCA Industries reports Q1 results</a></h4><ul>\n<li>CCA Industries (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/CAW\" title=\"CCA Industries Inc\">CAW</a>): Q1 EPS of $0.03</li>\n<li>Revenue of $4.68M (-32.7% Y/Y)</li>\n<li>Shares <font color=\"green\">+3.1%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173388\" data-linked=\"CCA Industries reports Q1 results\" data-tweet=\"$CAW - CCA Industries reports Q1 results https://seekingalpha.com/news/3173388-cca-industries-reports-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3173388-cca-industries-reports-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173381\" data-ts=\"1460728571\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SITC\" target=\"_blank\">SITC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173381-ddr-gains-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DDR gains after upgrade</a></h4><ul><li>An outlier to the upside among the shopping-center REITs today is DDR (DDR <font color='green'>+1.1%</font>) after &nbsp;an upgrade to Overweight at KeyBanc.</li><li>Now read:&nbsp;<a href=\"https://seekingalpha.com/article/3058816-ddr-is-moving-the-bar-but-the-yield-is-sub-par\" target=\"_blank\">DDR Is Moving The Bar But The Yield Is Sub-Par</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3173381\" data-linked=\"DDR gains after upgrade\" data-tweet=\"$SITC - DDR gains after upgrade https://seekingalpha.com/news/3173381-ddr-gains-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3173381-ddr-gains-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173370\" data-ts=\"1460726680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARIA\" target=\"_blank\">ARIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173370-phase-1-2-trial-of-ariad-pharmas-brigatinib-shows-100-one-year-survival-rate-in-late-stage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phase 1/2 trial of ARIAD Pharma&#39;s brigatinib shows 100% one-year survival rate in late-stage lung cancer patients; shares ahead 10% premarket</a></h4><ul>\n<li>ARIAD Pharmaceuticals (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ARIA\" title=\"ARIAD Pharmaceuticals, Inc.\">ARIA</a>) is up <font color=\"green\">10%</font> premarket on robust volume in response to its <a href=\"http://www.businesswire.com/news/home/20160415005047/en/ARIAD-Presents-Updated-Phase-12-Clinical-Data\" target=\"_blank\">announcement </a>of updated data from its ongoing Phase 1/2 study assessing brigatinib for the treatment of patients with advanced malignancies, including a certain type of non-small cell lung cancer (NSCLC). The results were presented at the 6th European Lung Cancer Conference in Geneva, Switzerland.</li>\n<li>The data included safety and pharmacokinetic data on 137 patients and efficacy analyses on 79 patients with ALK+ NSCLC who were on treatment for a median time of 12.6 months. The primary efficacy endpoint is overall response rate. Secondary endpoints include safety, tolerability, pharmacokinetics, progression-free survival (PFS) and overall survival.</li>\n<li>The overall survival rate at one year was 100% in patients who had not been treated with Pfizer's (NYSE:<a href=\"https://seekingalpha.com/symbol/PFE\" title=\"Pfizer Inc.\">PFE</a>) Xalkori (crizotinib) and 81% in those who had been treated with crizotinib. In 70 evaluable ALK+ NSCLC patients previously treated with crizotinib, median PFS was 13.4 months (median PFS in the crizotinib-naive group has not been reached). Almost all of the evaluable ALK+ NSCLC patients showed tumor shrinkage, with 25 (35.7%) experiencing 100% shrinkage of the target lesion.</li>\n<li>The most common treatment-emergent adverse events were nausea (52%), fatigue (42%), diarrhea (40%), headache (33%) and cough (32%).</li>\n<li>Phase 3-stage <a href=\"http://www.ariad.com/research-development/brigatinib/\" target=\"_blank\">brigatinib </a>is an oral inhibitor of an enzyme called <a href=\"https://en.wikipedia.org/wiki/Anaplastic_lymphoma_kinase\" target=\"_blank\">anaplastic lymphoma kinase</a> (ALK). The abnormal expression of ALK is a key driver of certain types of non-small cell lung cancer, neuroblastomas and anaplastic large cell lymphoma. It is not generally expressed in normal adult tissues so it is a promising therapeutic target.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173370\" data-linked=\"Phase 1/2 trial of ARIAD Pharma&#39;s brigatinib shows 100% one-year survival rate in late-stage lung cancer patients; shares ahead 10% premarket\" data-tweet=\"$ARIA $ARIA $PFE - Phase 1/2 trial of ARIAD Pharma&#39;s brigatinib shows 100% one-year survival rate in late-stage lung cancer patients; shares ahead 10% premarket https://seekingalpha.com/news/3173370-phase-1-2-trial-of-ariad-pharmas-brigatinib-shows-100-one-year-survival-rate-in-late-stage?source=tweet\" data-url=\"https://seekingalpha.com/news/3173370-phase-1-2-trial-of-ariad-pharmas-brigatinib-shows-100-one-year-survival-rate-in-late-stage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173367\" data-ts=\"1460726273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173367-infosys-up-5_3-early-on-revenue-beat-growth-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infosys up 5.3% early on revenue beat, growth guidance</a></h4><ul>   <li>Infosys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INFY\" title=\"Infosys Limited, Inc.\">INFY</a>) is <font color=\"green\">up 5.3%</font> premarket after today's <a href=\"https://seekingalpha.com/news/3173283-infosys-limited-eps-line-beats-revenue\" target=\"_blank\">fiscal Q4 earnings report</a> featured a revenue beat and solid guidance.</li>    <li>Revenues were up 13.3% on a headline basis but grew 15% in constant currency. Earnings were in line with expectations but grew 7% from the prior year.</li>    <li>Cash generation was strong in a \"volatile currency environment,\" CFO M.D. Ranganath said. Cash and equivalents rose to $5.2B on March 31 from last quarter's $4.765B.</li>    <li>Infosys is guiding to revenues growing 11.5%-13.5% in constant currency for the full year, and 11.8%-13.8% in dollar terms considering today's rates.</li>    <li>The company said Mohit Joshi, Ravi Kumar S and Sandeep Dadlani have been named as presidents, effective immediately.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3866016-infosys-become-good-stock\" target=\"_blank\"><b>Why Infosys Has Become A Good Stock To Own Again »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173367\" data-linked=\"Infosys up 5.3% early on revenue beat, growth guidance\" data-tweet=\"$INFY - Infosys up 5.3% early on revenue beat, growth guidance https://seekingalpha.com/news/3173367-infosys-up-5_3-early-on-revenue-beat-growth-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3173367-infosys-up-5_3-early-on-revenue-beat-growth-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173364\" data-ts=\"1460726019\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173364-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a> <font color='green'>+72%</font>. <a href='https://seekingalpha.com/symbol/GENE' title='GENETIC TECHNOLOGIES LTD'>GENE</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ARIA' title='ARIAD Pharmaceuticals, Inc.'>ARIA</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ATHM' title='Autohome Inc.'>ATHM</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='red'>-30%</font>. <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/RLYP' title='Relypsa, Inc.'>RLYP</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/MITL' title='Mitel Networks Corporation'>MITL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Co.'>SWN</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/DNR' title='Denbury Resources Inc.'>DNR</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3173364\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$GBSN-OLD $GENE $RGLS - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3173364-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3173364-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173361\" data-ts=\"1460725623\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHW\" target=\"_blank\">SCHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173361-schwab-profits-from-higher-rates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schwab profits from higher rates</a></h4><ul>\n<li>Q1 net income of $412M or $0.29 per share vs. $302M and $0.22 one year ago. Pretax profit margin of 37.1% up from 31.7%. ROE of 13% up from 10%.</li>\n<li>CFO Joe Martinetto: \"The ongoing effect of the Fed\u2019s initial interest rate hike in December has provided a glimpse of Schwab\u2019s earnings power as rates normalize.\" Indeed. Money market fund revenue jumped $61M from last quarter - not an insignificant amount given total income in Q1 was $412M. Net interest revenue in Q1 was $772M vs. $588M a year ago.</li>\n<li>New retail brokerage accounts of 163K down 8% from a year ago; total accounts of 6.9M up 3%.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3173352-charles-schwab-eps-line-beats-revenue\" target=\"_blank\">Charles Schwab EPS in-line, beats on revenue</a> (April 15)</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/SCHW\" title=\"The Charles Schwab Corporation\">SCHW</a> <font color=\"green\">+2.4%</font> premarket</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3964505-innovative-charles-b-schwab-b-set-reap-whirlwind-investing-changes\" target=\"_blank\">Innovative Charles <b>Schwab</b> Set To Reap The Whirlwind Of Investing Changes</a> (April 11)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173361\" data-linked=\"Schwab profits from higher rates\" data-tweet=\"$SCHW - Schwab profits from higher rates https://seekingalpha.com/news/3173361-schwab-profits-from-higher-rates?source=tweet\" data-url=\"https://seekingalpha.com/news/3173361-schwab-profits-from-higher-rates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173356\" data-ts=\"1460725424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGLS\" target=\"_blank\">RGLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173356-regulus-therapeutics-hcv-candidate-rgminus-101-in-combination-antivirals-shows-cure-rates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regulus Therapeutics&#39; HCV candidate RG-101, in combination with other antivirals, shows cure rates as high as 100% in eight weeks; shares up 11% premarket</a></h4><ul>\n<li>Regulus Therapeutics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/RGLS\" title=\"Regulus Therapeutics\">RGLS</a>) is up <font color=\"green\">11%</font> premarket on higher-than-normal volume in response to its announcement of additional interim results from its ongoing Phase 2 development of RG-101 for the treatment of chronic hepatitis C virus (HCV) infection. The data were presented at The International Liver Congress 2016 in Barcelona, Spain.</li>\n<li>The study was designed to assess a shortened four-week regimen of RG-101, 2 mg/kg administered via subcutaneous injection at day 1 and day 29, in combination with four weeks of a once/daily antiviral: Gilead Sciences' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GILD\" title=\"Gilead Sciences, Inc.\">GILD</a>) Harvoni (ledipasvir/sofosbuvir), J&amp;J's (NYSE:<a href=\"https://seekingalpha.com/symbol/JNJ\" title=\"Johnson &amp; Johnson\">JNJ</a>) Olysio (simeprevir) or Bristol-Myers Squibb's (NYSE:<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a>) Daklinza (daclatasvir). 79 treatment-naive HCV-1 and HCV-4 patients were enrolled in three arms: Harvoni: n=27; Olysio: n=27; Daklinza: n-25.</li>\n<li>Cure rates at week 8 for RG-101 + Harvoni, RG-101 + Olysio and RG-101 + Daklinza were 100%, 100% and 90.9%, respectively. Cure rates at week 12 were 100%, 93.3%, and 100%, respectively (one relapse in Olysio arm).</li>\n<li>\n<a href=\"http://www.regulusrx.com/therapeutic-areas/rg-101/\" target=\"_blank\">RG-101</a> is a <a href=\"http://www.regulusrx.com/about-micrornas/\" target=\"_blank\">microRNA</a> therapeutic, specifically a GalNAc-conjugated anti-microRNA targeting microRNA-122. MicroRNAs are small bits of RNA, typically 20 - 25 nucleotides long, that do not encode proteins but regulate gene expression. Researchers believe as many as two-thirds of human genes are regulated by microRNAs.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3113366-regulus-therapeutics-hcv-candidate-shows-97-percent-cure-rate-eight-weeks-mid-stage-study\" target=\"_blank\">Regulus Therapeutics' HCV candidate shows 97% cure rate after eight weeks in mid-stage study; shares up 43% premarket</a> (Feb. 17)</li>\n<li>Read now <a href=\"https://seekingalpha.com/article/3910256-regulus-add-help-regulate-hep-c-drug-costs\" target=\"_blank\">Regulus Add-On Could Help Regulate Hep C Drug Costs </a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173356\" data-linked=\"Regulus Therapeutics&#39; HCV candidate RG-101, in combination with other antivirals, shows cure rates as high as 100% in eight weeks; shares up 11% premarket\" data-tweet=\"$RGLS $RGLS $GILD - Regulus Therapeutics&#39; HCV candidate RG-101, in combination with other antivirals, shows cure rates as high as 100% in eight weeks; shares up 11% premarket https://seekingalpha.com/news/3173356-regulus-therapeutics-hcv-candidate-rgminus-101-in-combination-antivirals-shows-cure-rates?source=tweet\" data-url=\"https://seekingalpha.com/news/3173356-regulus-therapeutics-hcv-candidate-rgminus-101-in-combination-antivirals-shows-cure-rates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173354\" data-ts=\"1460725161\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSYS\" target=\"_blank\">SSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173354-stratasys-3d-systems-lower-citi-downgrades-3-d-printers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stratasys, 3D Systems lower as Citi downgrades 3-D printers</a></h4><ul>   <li>Stratasys (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SSYS\" title=\"Stratasys, Inc.\">SSYS</a>) and 3D Systems (NYSE:<a href=\"https://seekingalpha.com/symbol/DDD\" title=\"3D Systems Corp.\">DDD</a>) have sunk premarket -- <font color=\"red\">by 3.6%</font> and <font color=\"red\">by 3.8%</font> respectively -- after a Citi update on 3D printing <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/04/7844694/citi-downgrades-stratasys-to-neutral-3d-systems-to-sell\" target=\"_blank\">downgraded both stocks</a> on valuation.</li>    <li>Analyst Kenneth Wong downgraded 3D Systems to Sell, while boosting its price target after <a href=\"https://seekingalpha.com/news/3173123-big-rip-3d-bank-america-backs-ceo-choice\" target=\"_blank\">yesterday's pop</a>, to $15 from $10 -- about 18% below yesterday's closing price of $18.27.</li>    <li>The company's hire of CEO Vyomesh Joshi is welcomed, but upside looks overstated, Wong says -- and the prospect of an acquisition by HP is \"highly unlikely.\"</li>    <li>Stratasys gets a downgrade as well, to Neutral; \"near-term upside is limited\" as industry checks look soft. While unit volumes have held up, Wong says, there looks like a shift toward buying lower-priced systems, and service bureau utilization looks lower than usual.</li>    <li>Now read <a href=\"https://seekingalpha.com/article/3963247-stratasys-game-changing-printer\" target=\"_blank\"><b>Stratasys: Game Changing Printer? »</b></a>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3173354\" data-linked=\"Stratasys, 3D Systems lower as Citi downgrades 3-D printers\" data-tweet=\"$SSYS $SSYS $DDD - Stratasys, 3D Systems lower as Citi downgrades 3-D printers https://seekingalpha.com/news/3173354-stratasys-3d-systems-lower-citi-downgrades-3-d-printers?source=tweet\" data-url=\"https://seekingalpha.com/news/3173354-stratasys-3d-systems-lower-citi-downgrades-3-d-printers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173352\" data-ts=\"1460724907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHW\" target=\"_blank\">SCHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173352-charles-schwab-eps-in-line-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charles Schwab EPS in-line, beats on revenue</a></h4><ul>\n<li>Charles Schwab (NYSE:<a href=\"https://seekingalpha.com/symbol/SCHW\" title=\"The Charles Schwab Corporation\">SCHW</a>): Q1 EPS of $0.29 in-line.</li>\n<li>Revenue of $1.76B (+15.0% Y/Y) <font color=\"green\">beats by $10M</font>.</li>\n<li>Shares <font color=\"green\">+2.54%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173352\" data-linked=\"Charles Schwab EPS in-line, beats on revenue\" data-tweet=\"$SCHW - Charles Schwab EPS in-line, beats on revenue https://seekingalpha.com/news/3173352-charles-schwab-eps-in-line-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3173352-charles-schwab-eps-in-line-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173351\" data-ts=\"1460723856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EJ\" target=\"_blank\">EJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173351-e-house-going-private\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">E-House going private</a></h4><ul>\n<li>Company management is taking E-House (NYSE:<a href=\"https://seekingalpha.com/symbol/EJ\" title=\"E-House (China) Holdings Limited\">EJ</a>) private <a href=\"http://www.advfn.com/news_E-House-Enters-into-Definitive-Agreement-for-Going_71136279.html?adw=1126416\" target=\"_blank\">for $6.85 per share</a>, and appears to have the financing lined up. The deal is expected to close in H2.</li>\n<li>Shares <font color=\"green\">+2.55%</font> to $6.44 premarket.</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3964667-chinese-squeeze-outs-need-protect-u-s-investors\" target=\"_blank\">Chinese 'Squeeze Outs' And The Need To Protect U.S. Investors</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173351\" data-linked=\"E-House going private\" data-tweet=\"$EJ - E-House going private https://seekingalpha.com/news/3173351-e-house-going-private?source=tweet\" data-url=\"https://seekingalpha.com/news/3173351-e-house-going-private\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173347\" data-ts=\"1460723505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173347-cellectar-bio-showing-weakness-ahead-of-equity-offering-shares-down-18-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar Bio showing weakness ahead of equity offering; shares down 18% premarket</a></h4><ul>\n<li>Thinly traded nano cap Cellectar Biosciences (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CLRB\" title=\"Cellectar Biosciences, Inc.\">CLRB</a>) is down <font color=\"red\">18%</font> premarket on light volume. Shares have retreated <font color=\"red\">40%</font> since touching $5 last week. A $6M offering of stock and warrants is on deck. The <a href=\"https://www.sec.gov/Archives/edgar/data/1279704/000114420416094228/v436675_s1a.htm\" target=\"_blank\">S-1</a> was declared effective yesterday.</li>\n<li>\n<strong>Update</strong>: The company priced the offering at $2.13 per share and associated warrant, exercisable at $3.04. Closing date is April 20. Yesterday's close was $3.05.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173347\" data-linked=\"Cellectar Bio showing weakness ahead of equity offering; shares down 18% premarket\" data-tweet=\"$CLRB - Cellectar Bio showing weakness ahead of equity offering; shares down 18% premarket https://seekingalpha.com/news/3173347-cellectar-bio-showing-weakness-ahead-of-equity-offering-shares-down-18-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3173347-cellectar-bio-showing-weakness-ahead-of-equity-offering-shares-down-18-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173345\" data-ts=\"1460723434\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173345-micron-higher-after-raymond-james-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron higher after Raymond James upgrade</a></h4><ul>\n<li>Saying 3D NAND SSDs are coming, <a href=\"https://twitter.com/thenotablecalls/status/720947762859261952\" target=\"_blank\">Raymond James upgrades</a> Micron Technology (NASDAQ:<a href=\"https://seekingalpha.com/symbol/MU\" title=\"Micron Technology Inc.\">MU</a>) to Strong Buy with $17 price target.</li>\n<li>The stock's <font color=\"green\">higher by 2.9%</font> premarket to $10.70.</li>\n<li>Now read: <a href=\"https://seekingalpha.com/article/3965043-b-micron-b-awkward-vision\" target=\"_blank\"><b>Micron</b>: Awkward, But There Is Vision</a> (April 13)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173345\" data-linked=\"Micron higher after Raymond James upgrade\" data-tweet=\"$MU - Micron higher after Raymond James upgrade https://seekingalpha.com/news/3173345-micron-higher-after-raymond-james-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3173345-micron-higher-after-raymond-james-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173343\" data-ts=\"1460723334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESV\" target=\"_blank\">ESV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173343-ensco-sees-better-expected-q1-operating-revenues-dayrates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ensco sees better than expected Q1 operating revenues, dayrates</a></h4><ul>\n<li>Ensco (NYSE:<a href=\"https://seekingalpha.com/symbol/ESV\" title=\"Ensco PLC\">ESV</a>) discloses <a href=\"http://www.sec.gov/Archives/edgar/data/314808/000110465916111500/a16-8186_38k.htm\" target=\"_blank\">preliminary Q1 financial results</a>, and revises its planned 2016 capex to $400M.</li>\n<li>ESV expects Q1 operating revenues of $812M-$817M vs. $788M analyst consensus,  benefiting from better than expected 64%-66% fleet utilization and average  dayrates that fell by 3%-4% instead of a 7%-8% decline in its prior guidance.</li>\n<li>ESV <font color=\"red\">-7.7%</font> premarket following yesterday's announcement that it will begin a <a href=\"https://seekingalpha.com/news/3173222-ensco-launch-50m-share-offering\" target=\"_blank\">public offering</a> of 50M Class A ordinary shares.</li>\n<li>Update: ESV upsizes its public offering to 57M shares, priced at $9.25M, with an underwriters option to purchase up to an additional 8.55M shares.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173343\" data-linked=\"Ensco sees better than expected Q1 operating revenues, dayrates\" data-tweet=\"$ESV $VAL - Ensco sees better than expected Q1 operating revenues, dayrates https://seekingalpha.com/news/3173343-ensco-sees-better-expected-q1-operating-revenues-dayrates?source=tweet\" data-url=\"https://seekingalpha.com/news/3173343-ensco-sees-better-expected-q1-operating-revenues-dayrates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173339\" data-ts=\"1460722546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173339-citigroup-higher-premarket-earnings-drop-beat-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup higher premarket as earnings drop, but beat estimates</a></h4><ul>\n<li>Q1 net income of $3.5B or $1.10 per share vs. just over $4.8B and $1.52 (ex. DVA) one year ago. Expectations were for just $1.03 this year. $1.6B of the DTA utilized.</li>\n<li>TBVPS of $62.58 up 9% Y/Y. CET1 ratio of 12.3% up 120 basis points.</li>\n<li>CEO Michael Corbat: \"While our market-sensitive products clearly suffered from weak investor sentiment during the quarter, e continued to make progress in several key areas.\"</li>\n<li>Operating expenses of $10.5B in Q1 fell 3% from a year ago, thanks to Citi Holdings and legal charges, partly offset by repositioning costs.</li>\n<li>Loan loss allowance of $12.7B at quarter end, or 2.07% of total loans vs. $14.6B and 2.38% a year ago. Corporate non-accrual loans of $2.3B up 46% from last quarter, up 97% from a year ago (energy).</li>\n<li>Total loans of $619B about flat from a year ago, and deposits of $935B up 4%.</li>\n<li>Total markets &amp; securities services revenue of $4.075B down 15% Y/Y, with fixed-income revenue of $3.085B down 11%.</li>\n<li>Citi Holdings ending assets at $73B down from $81B last quarter and $130B a year ago. With the \"bad bank\" now representing such a small portion of overall bank assets, it will not be reported separately after this year.</li>\n<li>\n<a href=\"http://www.citigroup.com/citi/investor\" target=\"_blank\">Conference call </a>at 11 ET</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/3173328-citigroup-beats-0_07-beats-revenue\" target=\"_blank\">Citigroup beats by $0.07, beats on revenue</a> (April 15)</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/C\" title=\"Citigroup Inc.\">C</a> <font color=\"green\">+2.4%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173339\" data-linked=\"Citigroup higher premarket as earnings drop, but beat estimates\" data-tweet=\"$C - Citigroup higher premarket as earnings drop, but beat estimates https://seekingalpha.com/news/3173339-citigroup-higher-premarket-earnings-drop-beat-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3173339-citigroup-higher-premarket-earnings-drop-beat-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173338\" data-ts=\"1460722387\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROAN\" target=\"_blank\">ROAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173338-linn-energy-makes-interest-payments-to-use-grace-period-on-others\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Linn Energy makes some interest payments, to use grace period on others</a></h4><ul>\n<li>Linn Energy (LINE) and LinnCo (LNCO) <font color=\"green\">+20%</font> premarket after announcing they made ~$60M in interest payments on senior debt within the applicable 30-day grace periods, for which payment had been deferred from the  original March 15 due date.</li>\n<li>Linn elects to exercise 30-day grace periods for a $31M interest payment due April 15 and $27M in payments due May 1; failure to make payments would result in an event of default.</li>\n<li>Linn is in the process of exploring  strategic alternatives to strengthen its balance sheet.</li>\n<li>Now read <a href=\"https://seekingalpha.com/article/3964820-linn-energy-investors-get-case-bankruptcy\" target=\"_blank\"><strong>Linn Energy: What investors would get in the case of bankruptcy</strong></a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173338\" data-linked=\"Linn Energy makes some interest payments, to use grace period on others\" data-tweet=\"$ROAN $ROAN $LNCOQ - Linn Energy makes some interest payments, to use grace period on others https://seekingalpha.com/news/3173338-linn-energy-makes-interest-payments-to-use-grace-period-on-others?source=tweet\" data-url=\"https://seekingalpha.com/news/3173338-linn-energy-makes-interest-payments-to-use-grace-period-on-others\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173328\" data-ts=\"1460721715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173328-citigroup-beats-0_07-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup beats by $0.07, beats on revenue</a></h4><ul>\n<li>Citigroup (NYSE:<a href=\"https://seekingalpha.com/symbol/C\" title=\"Citigroup Inc.\">C</a>): Q1 EPS of $1.10 <font color=\"green\">beats by $0.07</font>.</li>\n<li>Revenue of $17.56B (-11.4% Y/Y) <font color=\"green\">beats by $100M</font>.</li>\n<li>Shares <font color=\"green\">+2.3%</font> PM.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173328\" data-linked=\"Citigroup beats by $0.07, beats on revenue\" data-tweet=\"$C - Citigroup beats by $0.07, beats on revenue https://seekingalpha.com/news/3173328-citigroup-beats-0_07-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3173328-citigroup-beats-0_07-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3173320\" data-ts=\"1460720653\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBSN\" target=\"_blank\">GBSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3173320-great-basin-q1-top-line-up-59-customer-base-up-120-shares-up-70-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Basin Q1 top line up 59%, customer base up 120%; shares up 70% premarket</a></h4><ul>\n<li>Nano cap Great Basin Scientific (NASDAQ:<a href=\"https://seekingalpha.com/symbol/GBSN-OLD\" title=\"Great Basin Scientific, Inc.\">GBSN</a>) is up<font color=\"green\"> 74%</font> premarket on increased volume in response to its announcement after the close yesterday of preliminary Q1 results. Revenues were $731K, up 59.4% yoy driven by 222 revenue-producing customers (+119.8%).</li>\n<li>The company needs to do something. It received a Staff Determination Letter from Nasdaq several days ago warning of delisting if the company fails to regain compliance with listing requirements.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3173320\" data-linked=\"Great Basin Q1 top line up 59%, customer base up 120%; shares up 70% premarket\" data-tweet=\"$GBSN $GBSN-OLD - Great Basin Q1 top line up 59%, customer base up 120%; shares up 70% premarket https://seekingalpha.com/news/3173320-great-basin-q1-top-line-up-59-customer-base-up-120-shares-up-70-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3173320-great-basin-q1-top-line-up-59-customer-base-up-120-shares-up-70-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":36,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}